Evidence map›Paper›PMID 42716032›Full record

ArticleJournal of neuromuscular diseases2026

Functional assessments used in routine care for duchenne muscular dystrophy in the United States: A survey of certified duchenne care centers.

Ruthwik Duvuru, Eric Camino, Rachel Schrader, Megan Freed, James Signorovitch, Jia Zhong, Shimin Bi, Susan J Ward, Aravindhan Veerapandiyan

Abstract read
In one paragraph

Article in Journal of neuromuscular diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruthwik DuvuruDivision of Neurology, Department of Pediatrics, Arkansas Children's Hospital, Little Rock, AR, USA.
Eric CaminoParent Project Muscular Dystrophy, Washington, DC, USA.
Rachel SchraderParent Project Muscular Dystrophy, Washington, DC, USA.
Megan FreedParent Project Muscular Dystrophy, Washington, DC, USA.
James SignorovitchAnalysis Group Inc., Boston, MA, USA.
Jia ZhongAnalysis Group Inc., Boston, MA, USA.
Shimin BiAnalysis Group Inc., Boston, MA, USA.
Susan J WardCollaborative Trajectory Analysis Project, Cambridge, MA, USA.
Aravindhan VeerapandiyanDivision of Neurology, Department of Pediatrics, Arkansas Children's Hospital, Little Rock, AR, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundClinical decision-making, disease progression monitoring, and evaluation of novel therapies for patients with Duchenne muscular dystrophy (DMD) rely on functional assessments. This study aimed to evaluate the use of functional assessments in routine DMD care and identify challenges encountered in their administration and documentation.MethodsA cross-sectional online survey was conducted in 2023 among 36 Certified Duchenne Care Centers (CDCCs) in the United States. Center directors collaborated with multidisciplinary teams to provide single response per center. The survey encompassed functional assessments for ambulatory and non-ambulatory patients, milestones definitions, documentation practices, and perceived barriers.ResultsTwenty-three CDCCs responded to the survey. Nearly half of the centers cared for up to 200 patients with DMD in the previous year, and all used electronic health record systems. Functional assessments were routinely conducted for both ambulatory and non-ambulatory patients, though variability was observed in assessment implementation, standardization procedures, training practices, documentation, and milestone definitions. Consistent use of assessments was reported in ambulatory patients; however, the extent of formal training and use of documented standard operating procedures varied across centers. Definitions of loss of ambulation were heterogeneous and often depended on the assessor's judgment. The most frequently reported barriers to conducting and documenting functional assessments included limited clinic time, insufficient staff hours, patient and caregiver burden, lack of convenient data-entry tools, and the time required for documentation.ConclusionsThe study provides an overview of functional assessment practices at CDCCs and identifies important opportunities to harmonize assessment implementation, documentation, and milestone definitions across centers.

Indexed as

DMDdystrophinopathyNSAAphysical therapy

Identifiers

PMID42716032
PMCPMC13558472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.